Weight Loss · Compound File

Semaglutide for weight loss

The original GLP-1 agonist that started the revolution. FDA-approved as Ozempic (diabetes) and Wegovy (obesity). Generic research semaglutide is the most affordable GLP-1 path in the Philippines.

Avg Loss

15.0%

Trial

68wk

Frequency

Weekly

FDA

Approved

Overview

Semaglutide is the most widely studied GLP-1 receptor agonist on the market. Phase 3 STEP trials demonstrated 14.9% average body weight reduction over 68 weeks at the 2.4mg obesity dose, and millions of patients have used it since FDA approval. In the Philippines, you have two real paths: branded Ozempic at pharmacies (intermittent stock, premium price) or research-grade generic semaglutide via research-peptide sellers (lower price, documentation required).

Brand vs research-grade

Ozempic vs generic semaglutide

Side-by-side
Property	Brand Ozempic	Generic semaglutide
Active ingredient	Semaglutide	Semaglutide
Mechanism	Identical	Identical
Form	Pre-filled injection pen	Lyophilized vial + syringe
Price (monthly)	$800–1200 USD	$50–150 USD
COA available	Pharmaceutical grade	Requires verification
Availability PH	Limited / very expensive	Available via suppliers

Semaglutide is a prescription medicine in the Philippines and prescribing belongs with a licensed Philippine physician. Readers comparing this against the dual and triple agonists usually want the peso figures, which sit with our partner and supplier. View Primara Labs pricing

Standard titration protocol

Suggested titration
Phase	Dose	Duration	Notes
Starting	0.25mg	Weeks 1–4	Tolerance building only, not therapeutic dose
Titration 1	0.5mg	Weeks 5–8	First noticeable appetite suppression
Titration 2	1mg	Weeks 9–16	Significant weight loss at this dose
Target	2.4mg	Ongoing	Maximum approved obesity dose (Wegovy)

Who should choose semaglutide

01New to GLP-1 peptides: extensive safety data makes it the lowest-risk starting point
02Budget-conscious users: semaglutide is the most affordable GLP-1 at therapeutic doses
03Want the most studied, proven compound with decades of research
04Have type 2 diabetes: semaglutide also has strong glucose-lowering data
05Plan to step up to tirzepatide or retatrutide later: semaglutide is a good introduction to GLP-1 effects

What to expect

Month 1

0.25mg is not a weight loss dose. It is tolerance building. Mild appetite changes. First-week nausea is common.

Month 2

At 0.5mg, clear appetite suppression. Many users report 2–4kg lost from reduced food intake alone.

Month 3–4

At 1mg, consistent weekly weight loss. Energy often improves. Body composition noticeably changing.

Month 5+

At higher doses (1.7–2.4mg), weight loss approaches the 15% clinical average. Plateau management becomes important.

↗ Related Filings

Our partner and supplier

What the newer agonists cost locally

Primara Labs, our partner and supplier, lists tirzepatide 15mg at PHP 2,100 and retatrutide 15mg at PHP 3,325 as research vials, priced in pesos from stock inside the Philippines. These are research materials, not pharmacy products, and anything you intend to use belongs in a conversation with a licensed Philippine physician. Metro Manila dispatch is same day, the rest of the country one to three business days.

View the Primara Labs catalogue